Peer-influenced content. Sources you trust. No registration required. This is HCN.
Conexiant
Laboratory analysis reveals montelukast demonstrates “significant binding” to multiple brain receptors, suggesting more extensive neurological activity than previously understood.
Allergy & Immunology December 4th 2024
Oncology News Central (ONC)
The inavolisib-based regimen more than doubled progression-free survival in PIK3CA-mutated breast cancers, offering a new standard of care for this challenging patient population.
Oncology, Medical October 21st 2024
Medical Professionals Reference (MPR)
In the BLUE-C trial, Cologuard Plus demonstrated a 93.9% sensitivity for colorectal cancer detection, significantly outperforming the 67.3% sensitivity of FIT.
Family Medicine/General Practice October 16th 2024
Epoch Health
The CDC investigation revealed that the 65 people who contracted Salmonella from the outbreak ranged from 2 to 88 years old, highlighting the wide demographic susceptibility to foodborne illnesses.
Emergency Medicine October 2nd 2024
The Epitomee capsule, a novel ingestible device for weight management, has shown promising results in clinical trials, with 55.5% of users losing at least 5% of their baseline body weight at 24 weeks.
Endocrinology, Diabetes, Metabolism September 25th 2024
Practical Neurology
Sanbexin’s sublingual formulation offers a potential paradigm shift in acute ischemic stroke treatment, enabling flexible administration outside traditional hospital settings.
Emergency Medicine September 25th 2024